Ponatinib may make allogeneic hematopoietic stem cell transplantation unnecessary for CML-BC under specific conditions, such as de novo cases: a case series of de novo CML-BC treated with ponatinib and no transplantation
Koyabu S et al. Leuk Lymphoma, June 2025
Link to full abstract